Date	Period	Revenue/Estimate	Earnings Call
May 15, 2024	2024/FY	449.000M / --	--
May 12, 2023	2023/FY	377.000M / --	--
May 13, 2022	2022/FY	348.000M / --	--
May 14, 2021	2021/FY	258.000M / --	--
May 29, 2020	2020/FY	266.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

May 15, 20242024/FY449.000M / ----

May 12, 20232023/FY377.000M / ----

May 13, 20222022/FY348.000M / ----

May 14, 20212021/FY258.000M / ----

May 29, 20202020/FY266.000M / ----

Unlock Free Earnings Estimates

Open Account

AKIBA Holdings Earnings Reports

AKIBA Holdings: Confirmation letter

Nov 13, 2024 19:08 ET

AKIBA Holdings: Half Year Report - Term 43 (2024/04/01 - 2025/03/31)

Nov 13, 2024 19:07 ET

AKIBA Holdings: Extraordinary Report

Nov 13, 2024 02:51 ET

AKIBA Holdings: Notice regarding the recording of extraordinary losses (provision for debt loss) and revisions to full-year consolidated earnings forecasts

Nov 13, 2024 02:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.